Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05199311
Title Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hackensack Meridian Health
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lombardi Comprehensive Cancer Center Recruiting Washington District of Columbia 20007 United States Details
John Theurer Cancer Center Recruiting Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from for the field